Skip to content

Alliance With Therapeutic Entourage in Support of Young Suicidal

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02524535
Acronym
IPSI2
Enrollment
292
Registered
2015-08-14
Start date
2007-04-30
Completion date
Unknown
Last updated
2015-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suicide

Brief summary

Regardless of age, the quality of hospital care, the confidence that the young can have in the health care team, joining parents are pivotal elements and influence followed. Family support is all the more important as 14% of young people realize a new suicidal act within three months of hospitalization for attempted suicide, and that the essential predictors appear to be the young age and quality of intra-family relationships. The main objective of this study is to determine, through the construction of an instrument to quantify the therapeutic alliance, defined by the characteristics of the mobilization of the entourage and the mutual commitments in the care of nursing teams and the entourage, the role of early therapeutic alliance with the entourage of suicidal youth 13-40 years, whether primosuicidants or repeat offenders, on short and medium term recurrences and early mortality.

Interventions

OTHERTherapeutic alliance

Sponsors

University Hospital, Caen
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
13 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Patient aged 13-40 years * From male or female * Supported the waning of a suicidal gesture. * speaking and writing fluent French * living in Upper or Lower Normandy * signed informed consent form, and at least one of his parents after oral and written information about the study for minors.

Exclusion criteria

* Age \<13 years or \> 40 years * Do not live in the Upper and Lower Normandy regions * Detained patient * forced hospitalization * Patient under guardianship * Patient with severe somatic pathology (cancer, heart failure, kidney or respiratory, central neurological disorder), scalable, or likely to be life-threatening within a period of less than one year * Refusal to participate in the study * Inability to respond

Design outcomes

Primary

MeasureTime frame
characteristics of the mobilization of the entourage evaluated with Family Assessment Devicebaseline

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026